State AL
Clinical Trials in Alabama
Recruiting clinical trials with at least one study location in Alabama. Data updated daily from ClinicalTrials.gov.
Top Conditions in Alabama
NCT06574165 N/A
Recruiting
Relationships of Affect and Neuroinflammation With Clinical Pain in Veterans Wit...
Condition
Fibromyalgia
Enrollment
60 pts
Location
United States
Sponsor
VA Office of Research and Deve
NCT05757102 Phase 3
Recruiting
A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/V...
Condition
Asthma
Enrollment
292 pts
Location
United States, Argentina, Australia
Sponsor
GlaxoSmithKline
NCT04634552 Phase 2
Recruiting
A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myel...
Condition
Hematological Malignancies
Enrollment
510 pts
Location
United States, Belgium, China
Sponsor
Janssen Research & Development
NCT07011914 N/A
Recruiting
Care in Multiple Sclerosis (MS)
Condition
Multiple Sclerosis
Enrollment
386 pts
Location
United States
Sponsor
NYU Langone Health
NCT06651606 N/A
Recruiting
Preventing Relapse of Problem Behavior Through Behavioral Economics: A Translati...
Condition
Problem Behavior
Enrollment
24 pts
Location
United States
Sponsor
Oakland University
NCT07014748 N/A
Recruiting
SAFETY: Stabilization Points to Third Hospital Line Assessment oF the Impact of ...
Condition
Traumatic Brain Hemorrhage
Enrollment
600 pts
Location
United States, Ukraine
Sponsor
InfraScan, Inc.
NCT04665739 Phase 2
Recruiting
Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive...
Condition
Advanced Lung Neuroendocrine Tumor
Enrollment
70 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT06232304 N/A
Recruiting
Transforming Care for Individuals With Childhood-onset Systemic Lupus Erythemato...
Condition
Systemic Lupus Erythematosus of Childhood (Disorder)
Enrollment
175 pts
Location
United States, Canada
Sponsor
Michigan State University
NCT06118515 Phase 1
Recruiting
A Safety Assessment of Oral Letermovir in Infants With Symptomatic Congenital Cy...
Condition
Congenital Cytomegalovirus Infection
Enrollment
12 pts
Location
United States
Sponsor
National Institute of Allergy
NCT04809740 N/A
Recruiting
Evaluating the Implementation and Impact of Navigator-delivered ePRO System
Condition
Cancer
Enrollment
7,500 pts
Location
United States
Sponsor
University of Alabama at Birmi
NCT06335524 N/A
Recruiting
Infant-Maternal Partnership and Cognitive Training Study for Preterm Infants
Condition
Child Development
Enrollment
188 pts
Location
United States
Sponsor
University of Alabama at Birmi
NCT04711824 Phase 1, Phase 2
Recruiting
Study of Stereotactic Radiosurgery With Olaparib Followed by Durvalumab and Phys...
Condition
Breast Cancer
Enrollment
41 pts
Location
United States
Sponsor
Colette Shen
NCT06389136 Phase 3
Recruiting
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Der...
Condition
Atopic Dermatitis
Enrollment
200 pts
Location
United States, Canada, Colombia
Sponsor
AbbVie
NCT04954664 N/A
Recruiting
Ridge Augmentation Using Allograft Particles Hydrated With or Without Recombinan...
Condition
Dental Implant
Enrollment
44 pts
Location
United States
Sponsor
University of Alabama at Birmi
NCT05079282 Phase 1
Recruiting
Study of ONO-4685 in Patients With Relapsed or Refractory T Cell Lymphoma
Condition
Relapsed or Refractory T Cell Lymphoma
Enrollment
217 pts
Location
United States
Sponsor
Ono Pharmaceutical Co. Ltd
NCT05440708 Phase 1, Phase 2
Recruiting
A Study of TTI-101 as Monotherapy and in Combination in Participants With Locall...
Condition
Hepatocellular Carcinoma
Enrollment
178 pts
Location
United States
Sponsor
Tvardi Therapeutics, Incorpora
NCT05183048 EARLY_Phase 1
Recruiting
Comparison of 89Zr Panitumumab and (18)F-Fluorodeoxyglucose to Identify Head and...
Condition
Head and Neck Squamous Cell Carcinoma
Enrollment
14 pts
Location
United States
Sponsor
University of Alabama at Birmi
NCT05918861 Phase 3
Recruiting
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Rece...
Condition
Acute Coronary Syndrome
Enrollment
2,000 pts
Location
United States, Canada, Puerto Rico
Sponsor
DalCor Pharmaceuticals
NCT06827990 N/A
Recruiting
GORE® Ascending Stent Graft in the Treatment of De Novo Type A Aortic Dissection...
Condition
Aortic Dissection
Enrollment
112 pts
Location
United States
Sponsor
W.L.Gore & Associates
NCT05033990 N/A
Recruiting
SPIROMICS Study of Early COPD Progression (SOURCE)
Condition
COPD, Early-Onset
Enrollment
1,000 pts
Location
United States
Sponsor
University of Massachusetts, W
NCT06807268 Phase 3
Recruiting
A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years o...
Condition
Eczema
Enrollment
150 pts
Location
United States, China, Germany
Sponsor
Pfizer
NCT05965518 N/A
Recruiting
High-Intensity Exercise to Combat Vascular and Cognitive Dysfunction in Adults W...
Condition
HIV
Enrollment
60 pts
Location
United States
Sponsor
University of Alabama at Birmi
NCT06188585 N/A
Recruiting
Randomized Trial of UI-EWD vs. Conventional Endoscopic Therapy for Nonvariceal U...
Condition
Acute Gastrointestinal Bleeding
Enrollment
278 pts
Location
United States, Canada, Denmark
Sponsor
Medtronic - MITG
NCT03435796 Phase 2, Phase 3
Recruiting
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Condition
Neoplasms
Enrollment
1,541 pts
Location
United States, Australia, Austria
Sponsor
Celgene
NCT06541262 Phase 1, Phase 2
Recruiting
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory...
Condition
Neuroblastoma
Enrollment
104 pts
Location
United States, Canada
Sponsor
Milton S. Hershey Medical Cent